Cline Christopher R.
CIK: 0001943192•CHIEF FINANCIAL OFFICER
Officer
Primary company: Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. is a corporate insider (CHIEF FINANCIAL OFFICER) at Travere Therapeutics, Inc. (TVTX) filing SEC Form 4 transactions. 47 transactions, totaling $0 in purchases and $1,253,320 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 20,000 | $17.44 | $349K | 0 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Sale | 400 | $65.31 | $26K | 87,508 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Sale | 1,900 | $63.69 | $121K | 87,908 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Sale | 20,735 | $62.61 | $1.30M | 89,808 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Sale | 27,473 | $62.00 | $1.70M | 110,543 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Exercise | 20,000 | $17.44 | $349K | 138,016 | 9/15/2026 Filed: 9/15/2026 | Filing → | |
| Sale | 1,014 | $42.61 | $43K | 116,899 | 4/15/2026 Filed: 4/13/2026 | Filing → | |
| Sale | 7,239 | $41.93 | $304K | 117,913 | 4/14/2026 Filed: 4/13/2026 | Filing → | |
| Sale | 9 | $41.07 | $370 | 125,152 | 4/14/2026 Filed: 4/13/2026 | Filing → | |
| Sale | 65 | $28.85 | $2K | 125,161 | 4/13/2026 Filed: 4/13/2026 | Filing → | |
| Award | 14,000 | - | - | 125,226 | 4/13/2026 Filed: 4/13/2026 | Filing → | |
| Sale | 7,242 | $32.12 | $233K | 112,971 | 2/3/2026 Filed: 1/31/2026 | Filing → | |
| Award | 75,000 | $33.09 | $2.48M | 75,000 | 1/31/2026 Filed: 1/31/2026 | Filing → | |
| Award | 28,130 | - | - | 120,213 | 1/31/2026 Filed: 1/31/2026 | Filing → | |
| Exercise | 20,000 | - | - | 0 | 12/1/2025 Filed: 12/3/2025 | Filing → | |
| Sale | 20,000 | $35.01 | $700K | 92,083 | 12/1/2025 Filed: 12/3/2025 | Filing → | |
| Exercise | 20,000 | $16.23 | $325K | 112,083 | 12/1/2025 Filed: 12/3/2025 | Filing → | |
| Sale | 119 | $19.71 | $2K | 92,083 | 9/4/2025 Filed: 9/5/2025 | Filing → | |
| Sale | 454 | $18.20 | $8K | 92,202 | 9/3/2025 Filed: 9/5/2025 | Filing → | |
| Sale | 470 | $17.31 | $8K | 92,656 | 8/27/2025 Filed: 8/28/2025 | Filing → |
Type
Exercise
Shares
20,000
Price
$17.44
Value
$349K
Type
Sale
Shares
400
Price
$65.31
Value
$26K
Type
Sale
Shares
1,900
Price
$63.69
Value
$121K
Type
Sale
Shares
20,735
Price
$62.61
Value
$1.30M
Type
Sale
Shares
27,473
Price
$62.00
Value
$1.70M
Type
Exercise
Shares
20,000
Price
$17.44
Value
$349K
Type
Sale
Shares
1,014
Price
$42.61
Value
$43K
Type
Sale
Shares
7,239
Price
$41.93
Value
$304K
Type
Sale
Shares
9
Price
$41.07
Value
$370
Type
Sale
Shares
65
Price
$28.85
Value
$2K
Type
Award
Shares
14,000
Price
-
Value
-
Type
Sale
Shares
7,242
Price
$32.12
Value
$233K
Type
Award
Shares
75,000
Price
$33.09
Value
$2.48M
Type
Award
Shares
28,130
Price
-
Value
-
Type
Exercise
Shares
20,000
Price
-
Value
-
Type
Sale
Shares
20,000
Price
$35.01
Value
$700K
Type
Exercise
Shares
20,000
Price
$16.23
Value
$325K
Type
Sale
Shares
119
Price
$19.71
Value
$2K
Type
Sale
Shares
454
Price
$18.20
Value
$8K
Type
Sale
Shares
470
Price
$17.31
Value
$8K
AI Agent
Try asking...